Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau 2024-06-26 20:56
Fufang E'jiao Syrup's Breakthrough Research on Cancer-Related Fatigue Receives "Special Excellence Award" at 2024 ASCO Annual Meeting 2024-06-26 18:42
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA 2024-06-26 12:36
Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever 2024-06-26 09:17
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation 2024-06-25 21:00
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services 2024-06-25 20:00
NX Group Signs Strategic Partnership Agreement with Controlant of Iceland 2024-06-25 14:00
Science and Technology Daily: China's Fertile Grounds for Innovation 2024-06-24 21:41
Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established 2024-06-24 21:00
iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson's Disease 2024-06-24 20:00
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024 2024-06-24 20:00
Wingderm® Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions 2024-06-24 12:31
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM 2024-06-20 14:51
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A 2024-06-19 21:00
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma 2024-06-19 19:30
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation 2024-06-19 19:00
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health 2024-06-19 18:10
Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens 2024-06-19 16:44
VUNO PRESENTS CUTTING-EDGE AI BRAIN TECHNOLOGY AT AAIC - ANALYZING MRI SCANS IN <1 MINUTE TO SUPPORT DIAGNOSIS OF ALZHEIMER'S DISEASE 2024-06-19 14:14
1 26 27 28 29 30 800